Comparison Between Non-High-Density Lipoprotein Cholesterol and Low-Density Lipoprotein Cholesterol to Estimate Cardiovascular Risk Using a Multivariate Model

被引:7
|
作者
Palazon-Bru, Antonio [1 ]
Antonio Carbayo-Herencia, Julio [1 ,2 ]
Simarro-Rueda, Marta [3 ]
Miguel Artigao-Rodenas, Luis [4 ]
Antonio Divison-Garrote, Juan [5 ]
Molina-Escribano, Francisca [6 ]
Ponce-Garcia, Isabel [7 ]
Francisco Gil-Guillen, Vicente [8 ]
Ponce-Garcia, I
Simarro-Rueda, M.
Carbayo-Herencia, J. A.
Palazon-Bru, Antonio [1 ]
Divison-Garrote, J. A.
Artigao-Rodenas, L. M.
Gil-Guillen, V
Sanchis-Domenech, C.
Masso-Orozco, J.
Torres-Moreno, P.
Navarro-Sanchez, L.
Gonzalez-Lozano, B.
Martinez-Ramirez, M.
Martinez-Navarro, E.
Rodriguez-Panos, B.
Garcia-Gosalvez, F.
Molina-Escribano, F.
Martinez-Lopez, R.
Lopez-Abril, J.
Caldevilla-Bernardo, D.
Lopez-de-Coca-y-Fernandez-Valencia, E.
Argandona-Palacios, E.
Monedero-Laorden, J.
Campayo-Serrano, A.
机构
[1] Miguel Hernandez Univ, Dept Clin Med, Carretera Valencia Alicante S-N, Alacant 03550, Spain
[2] Quironsalud Hosp, Lipids Unit, Albacete, Spain
[3] Zone IV Primary Care Hlth Ctr, Hlth Syst Castilla Mancha, Albacete, Spain
[4] Zone III Primary Care Hlth Ctr, Hlth Syst Castilla Mancha, Albacete, Spain
[5] Catholic Univ Murcia, Cathedra Primary Hlth Care, Murcia, Spain
[6] Casas Ibanez Primary Care Hlth Ctr, Hlth Syst Castilla Mancha, Albacete, Spain
[7] Alcadozo Primary Care Hlth Ctr, Hlth Syst Castilla Mancha, Albacete, Spain
[8] Miguel Hernandez Univ, Dept Clin Med, Alacant, Spain
关键词
cardiovascular diseases/epidemiology; cholesterol; HDL; LDL/blood; cholesterol/blood; models; statistical; CORONARY-HEART-DISEASE; NON-HDL CHOLESTEROL; APOLIPOPROTEIN-B; LDL-CHOLESTEROL; ISCHEMIC-STROKE; LIPID MEASURES; INDIVIDUALS; PREDICTION; EVENTS; METAANALYSIS;
D O I
10.1097/JCN.0000000000000534
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Although studies exist comparing low-density lipoprotein cholesterol (LDL-C) and non-high-density lipoprotein cholesterol (HDL-C) in the development of cardiovascular disease (CVD), most have limitations in the mathematical models used to evaluate their prognostic power adjusted for the other risk factors (cardiovascular risk). Objective: The aim of this study was to compare LDL-C and non-HDL-C in patients with CVD to determine whether both parameters predict CVD similarly. Methods: A cohort of 1322 subjects drawn from the general population of a Spanish region was followed between 1992 and 2006. The outcome was time to CVD. Secondary variables were gender, age, hypertension, diabetes, personal history of CVD, current smoker, body mass index, LDL-C, and non-HDL-C. Two CVD prediction models were constructed with the secondary variables, with only the lipid parameter varying (non-HDL-C or LDL-C). In the construction of the models, the following were considered: multiple imputation, events per variable of 10 or more, and continuous predictors as powers. The validation was conducted by bootstrapping obtaining the distribution of the C statistic (discrimination) and the probabilities observed by smooth curves. These results were compared in both models using graphical and analytical testing. Results: There were a total of 137 CVD events. The models showed no differences in the distributions of the C statistic (discrimination, P = .536) or in the calibration plot. Conclusions: In our population, LDL-C and non-HDL-C were equivalent at predicting CVD. More studies using this methodology are needed to confirm these results.
引用
收藏
页码:E17 / E23
页数:7
相关论文
共 50 条
  • [41] Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and Helicobacter pylori infection
    Jiayu Qiu
    Dingwei Liu
    Chengyun Wu
    Hao Chen
    Jinliang Xie
    Sihai Chen
    Youhua Wang
    Feng Zhou
    Jiasheng Fang
    Qirui Lai
    Rulin Zhao
    Yong Xie
    Scientific Reports, 15 (1)
  • [42] Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and sarcopenia based on NHANES
    Ma, Yanming
    Li, Lingjiang
    Wang, Renji
    Yu, Xiaojun
    Wang, Yinguang
    Li, Ruoyu
    Hu, Huimin
    Wang, Xiaodong
    Hao, Dingjun
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [43] Non-high-density lipoprotein cholesterol: current status as cardiovascular marker
    Verbeek, Rutger
    Hovingh, G. Kees
    Boekholdt, S. Matthijs
    CURRENT OPINION IN LIPIDOLOGY, 2015, 26 (06) : 502 - 510
  • [44] Apolipoprotein B, Low-Density Lipoprotein Particle Number, Non-High-Denisity Lipoprotein Cholesterol, Low-Density Lipoprotein Cholesterol, and Total Cholesterol for Atherosclerotic Cardiovascular Disease Risk Prediction in Young Adults
    Wilkins, John T.
    Ning, Hongyan
    Sawicki, Konrad
    Sawicki, Konrad T.
    Sniderman, Allan D.
    Otvos, James D.
    Rana, Jamal S.
    Murthy, Venkatesh
    Murthy, Venkatesh L.
    Shah, Ravi V.
    Allen, Norrina B.
    Lloyd-Jones, Donald
    CIRCULATION, 2023, 147
  • [45] Residual Atherosclerotic Cardiovascular Disease Risk: Focus on Non-High-Density Lipoprotein Cholesterol
    Luo, Yonghong
    Peng, Daoquan
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2023, 28
  • [46] Interventions to Lower Low-Density Lipoprotein Cholesterol and Cardiovascular Risk
    Navarese, Eliano P.
    Kolodziejczak, Michalina
    De Servi, Stefano
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (04): : 439 - 439
  • [47] Are You Targeting Non-High-Density Lipoprotein Cholesterol?
    Robinson, Jennifer G.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 55 (01) : 42 - 44
  • [48] Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: MERCURY II trial
    Ballantyne, Christie M.
    Raichlen, Joel S.
    Cain, Valerie A.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (06) : E59 - E59
  • [49] Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol
    Liliana Fonseca
    Sílvia Paredes
    Helena Ramos
    José Carlos Oliveira
    Isabel Palma
    Lipids in Health and Disease, 19
  • [50] Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol
    Fonseca, Liliana
    Paredes, Silvia
    Ramos, Helena
    Oliveira, Jose Carlos
    Palma, Isabel
    LIPIDS IN HEALTH AND DISEASE, 2020, 19 (01)